Showing results (131-140 of 243) with videos related to
Sort By:
Pageof 25
Cancer Research|June 1, 1985
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patientsR Kurzrock, M G Rosenblum, S A Sherwin, et al.Journal of Assisted Reproduction and Genetics|February 26, 2022
An assessment of oncofertility content on reproductive endocrinology and infertility clinic websitesVaidehi Mujumdar, Kavya Shivashankar, Rachel Madding, et al.Vaccine|September 27, 2025
Time intervals from vaccine administration to reimbursement for an updated Advisory Committee on Immunization Practices (ACIP) recommendation: Evidence from pneumococcal conjugate vaccinations among privately insured adults, 2021-2022Hannah G Rosenblum, Charles M Carpenter, Tina Trosclair, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicityM G Rosenblum, C F Verschraegen, J L Murray, et al.Physica A|September 7, 2001
Scaling and universality in heart rate variability distributionsIvanov PCh, M G Rosenblum, C K Peng, et al.Cancer Research|June 1, 2013
Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumorsHong Zhou, Walter N Hittelman, Hideo Yagita, et al.Obstetrics and Gynecology|July 14, 2021
Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine IndividualsConnie D Cao, Molly A Amero, Katrina A Marcinkowski, et al.Cancer Chemotherapy and Pharmacology|February 18, 2011
Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropinIsao Kanatani, Xinjian Lin, Xiaoqin Yuan, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 1995
Amino acid sequence analysis, gene construction, cloning, and expression of gelonin, a toxin derived from Gelonium multiflorumM G Rosenblum, W A Kohr, K L Beattie, et al.Molecular Cancer Therapeutics|February 3, 2007
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMAMi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.Pageof 25